scholarly article | Q13442814 |
P50 | author | Michael Pfreundschuh | Q1928879 |
Uğur Şahin | Q2505089 | ||
Özlem Türeci | Q92379963 | ||
Karl Schwechheimer | Q125261551 | ||
P2093 | author name string | Feiden W | |
Moringlane JR | |||
Eberle T | |||
Zwick C | |||
Koslowski M | |||
Romeike B | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3916-3922 | |
P577 | publication date | 2000-10-01 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | Expression of cancer testis genes in human brain tumors. | |
P478 | volume | 6 |
Q42398133 | A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies. |
Q34842204 | All in the head: obstacles for immune rejection of brain tumours |
Q33648189 | Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics |
Q36623761 | Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications |
Q34111864 | Cancer-testis (CT) antigen expression in medulloblastoma. |
Q37851972 | Cellular Immunotherapy for High-Grade Glioma |
Q40738333 | Consequences of point mutations in melanoma-associated antigen 4 (MAGE-A4) protein: Insights from structural and biophysical studies |
Q35589288 | Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway |
Q37392057 | Dendritic-cell- and peptide-based vaccination strategies for glioma. |
Q26747510 | Ectopic Expression of Testis Germ Cell Proteins in Cancer and Its Potential Role in Genomic Instability |
Q41608074 | Expression of cancer-testis genes in brain tumors |
Q37038420 | Expression of cancer/testis antigens is correlated with improved survival in glioblastoma |
Q48412388 | Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy. |
Q35116913 | Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks |
Q24615166 | Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma |
Q33393581 | Genome-wide analysis of cancer/testis gene expression |
Q39211999 | HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression. |
Q33802891 | High expression and frequently humoral immune response of melanoma-associated antigen D4 in glioma |
Q39970401 | Human glioma cell culture: two FCS-free media could be recommended for clinical use in immunotherapy |
Q38953024 | Improving vaccine efficacy against malignant glioma |
Q33334409 | Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation |
Q47618141 | NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma |
Q35955393 | Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients |
Q34491734 | Profound tumor-specific Th2 bias in patients with malignant glioma |
Q35789880 | Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification |
Q42539488 | Rethinking immunotherapy for brain cancers in the light of cancer complexity |
Q39609814 | Selective cancer-germline gene expression in pediatric brain tumors |
Q25256674 | Sperm protein 17 is expressed in human nervous system tumours. |
Q33750862 | T-cell-based therapies for malignancy and infection in childhood |
Q34146229 | The SSX family of cancer-testis antigens as target proteins for tumor therapy |
Q37849976 | The biology of cancer testis antigens: putative function, regulation and therapeutic potential |
Q90728910 | The ectopic expression of meiCT genes promotes meiomitosis and may facilitate carcinogenesis |
Q36424131 | The significance of MAGED4 expression in non-small cell lung cancer as analyzed by real-time fluorescence quantitative PCR. |
Q39633756 | Use of dentritic cells pulsed with HLA-A2-restricted MAGE-A1 peptide to generate cytotoxic T lymphocytes against malignant glioma |
Search more.